// COMPANY
Kalivir Immunotherapeutics
SECTOR BIOTECHMENTIONS 1LAST SEEN AUGUST 26, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
funding·Parsers VC·AUGUST 26, 2026
“Kalivir Immunotherapeutics ($14M Series A, oncolytic immunotherapy)”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.